Photosensitivity Clinical Trial
Official title:
Pilot Studies Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects
The purpose of this study is three-fold. First, researchers will assess whether subjects who have clinically abnormal reactions to sunlight (photosensitivity) have increased levels of microvesicle particles (MVP) following ultraviolet B (UVB) treatment to localized area of skin. Second, researchers will assess if topical application of the medicine imipramine will block UVB-induced MVP release. Third, researchers will assess if the topical cream will block UVB-induced increased erythema reactions (reddening of the skin).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04811079 -
The Role of Spectral Filtering in a Spectrally Adjustable Ocular Photosensitivity Analyzer
|
N/A | |
| Completed |
NCT04654312 -
Study to Evaluate the Influence of Hydrochlorothiazide on Dermal Photosensitivity and DNA Stability - a Pilot Study (HCTox Study)
|
Phase 1 | |
| Completed |
NCT01942564 -
The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study
|
N/A |